Gelatinase B: a tuner and amplifier of immune functions

被引:364
作者
Opdenakker, G [1 ]
Van den Steen, PE [1 ]
Van Damme, J [1 ]
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, Lab Mol Immunol, B-3000 Louvain, Belgium
关键词
D O I
10.1016/S1471-4906(01)02023-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Gelatinase B (matrix metalloproteinase-9) is a secreted multidomain enzyme that is important for the remodeling of the extracellular matrix and the migration of normal and tumor cells. It cleaves denatured collagens (gelatins) and type IV collagen, which is present in basement membranes. In the immune system, this cleavage helps lymphocytes and other leukocytes to enter and leave the blood and lymph circulations. Gelatinase B also cleaves myelin basic protein and type II gelatins, and this clipping leads to remnant epitopes that generate autoimmunity, the so-called REGA model of autoimmunity. Recently, gelatinase B has been found to process cytokines and chemokines, resulting in skewed immune functions. Therefore, gelatinase B, often considered as a pure effector molecule, acts as a switch and catalyst in both innate and specific immunity, and constitutes a prototypic example of the regulation of immune functions by proteolysis.
引用
收藏
页码:571 / 579
页数:9
相关论文
共 90 条
[1]  
Aoudjit F, 1998, J IMMUNOL, V160, P2967
[2]   Human monocyte-derived dendritic cells produce bioactive gelatinase B:: Inhibition by IFN-ß [J].
Bartholomé, EJ ;
Van Aelst, I ;
Koyen, E ;
Kiss, R ;
Willems, F ;
Goldman, M ;
Opdenakker, G .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (07) :495-501
[3]   HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages [J].
Bellosta, S ;
Via, D ;
Canavesi, M ;
Pfister, P ;
Fumagalli, R ;
Paoletti, R ;
Bernini, F .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (11) :1671-1678
[4]   Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids [J].
Berton, A ;
Rigot, V ;
Huet, E ;
Decarme, M ;
Eeckhout, Y ;
Patthy, L ;
Godeau, G ;
Hornebeck, W ;
Bellon, G ;
Emonard, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) :20458-20465
[5]  
Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.3.CO
[6]  
2-S
[7]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[8]   METALLOPROTEINASES AND COLLAGENASE INHIBITORS IN RHEUMATOID SYNOVIAL-FLUID [J].
CAWSTON, TE ;
MERCER, E ;
DESILVA, M ;
HAZLEMAN, BL .
ARTHRITIS AND RHEUMATISM, 1984, 27 (03) :285-290
[9]   3-DIMENSIONAL STRUCTURE OF INTERLEUKIN-8 IN SOLUTION [J].
CLORE, GM ;
APPELLA, E ;
YAMADA, M ;
MATSUSHIMA, K ;
GRONENBORN, AM .
BIOCHEMISTRY, 1990, 29 (07) :1689-1696
[10]  
CORCORAN ML, 1992, J BIOL CHEM, V267, P515